Neuland Labs posted strong FY26 results: Revenue at ₹2023 Cr, Profit at ₹364 Cr, EPS ₹283.71. It proposes a ₹34/share dividend.

Neuland Laboratories LimitedNEULANDLAB · Filed with the exchange

The company approves ₹143.4 Cr for 120.5 KL capacity expansion at Unit 1 to meet growing demand.

Dr. Mauricio Futran was appointed as an Additional Director.

No comments yet. Be the first.

More from Neuland Laboratories Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.